http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2500540-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b2b250d3f776665fc10408a3fc94c37 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-602 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L67-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G63-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G63-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L67-04 |
| filingDate | 2008-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00a9fe112bd945f13aae515902c7d31c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13372a8b5d952041e46f04564043ee67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cf2ff123056feb95c595b5cbd9fdc54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6dc8e94a14689335779df365654bd38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d237a595121a14b344ce62ee1cadaa2c |
| publicationDate | 2014-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2500540-T3 |
| titleOfInvention | Implantable devices that provide controlled release of hydrophobic drugs |
| abstract | An implantable device comprising a coating comprising a composition, where the coating has a thickness of <= 6 microns and is completely degraded, which means the loss of at least 95% of its mass, or is substantially completely degraded , which means the loss of at least 75% of its mass, in 12 months when exposed to physiological conditions, where the composition comprises a biodegradable block copolymer, where the copolymer: is derived from at least two polar monomers selected from glycolide (GA), D-lactide (DLA), L-lactide (LLA), D, L-lactide (DLLA) and meso-lactide (MLA) and at least one non-polar monomer selected from valerolactone (VL), caprolactone ( CL), trimethylene carbonate (TMC), dioxanone (DS), hydroxybutyrate (HB), and hydroxivalerate (HV); it has a Tg of -150 ° C at 100 ° C; it has a polymeric average molecular weight (Mn) of 10 kDa to 500 kDa; and it degrades completely, which means the loss of at least 95% of its mass, or it degrades substantially completely, which means the loss of at least 75% of its mass, in 12 months; and where: each type of monomer independently has 10 to 5,000 units in the copolymer; and the mole% of each type of monomer is independently from 5% to 90%. |
| priorityDate | 2007-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 538.